Latest & greatest articles for hiv

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hiv or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hiv and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hiv

1. Oral mycobiome in atopic dermatitis, leukemia and HIV: a systematic review based on identification methods

Oral mycobiome in atopic dermatitis, leukemia and HIV: a systematic review based on identification methods Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

2. Neuropsychiatric outcomes in children, adolescents and young adults with vertically transmitted HIV: a systematic review

Neuropsychiatric outcomes in children, adolescents and young adults with vertically transmitted HIV: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2020 PROSPERO

3. HIV status disclosure to male partners among Ethiopian women: a systematic review and meta-analysis

HIV status disclosure to male partners among Ethiopian women: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

4. What methods have been effective in promoting uptake of Pre-exposure prophylaxis (PrEP) among individuals at high risk of HIV, excluding men who have sex with men

What methods have been effective in promoting uptake of Pre-exposure prophylaxis (PrEP) among individuals at high risk of HIV, excluding men who have sex with men Knowledge & Library Services (KLS) Evidence Briefing What methods have been effective in promoting uptake of Pre- exposure prophylaxis (PrEP) among individuals at high risk of HIV, excluding men who have sex with men (MSM), in developed cities comparable to London Nicola Pearce-Smith March 15 th 2019 What methods have been effective (...) in promoting uptake of PrEP among individuals at high risk of HIV KLS Evidence Briefing March 19th 2019 Research question This briefing summarises the evidence on the uptake of PrEP amongst high risk groups such as women, transgender, black Africans, sex workers, drug addicts and young people, from January 1 st 2017 to February 28 th 2019. Key messages • Barriers to PrEP uptake identified across all risk groups were safety, side effects, lack of knowledge, medication regimen, socioeconomic factors, stigma

2020 Public Health England - Evidence Briefings

5. The risk of HIV among women after acquiring a sexually transmitted infection (STI) and considerations for their use of PrEP

The risk of HIV among women after acquiring a sexually transmitted infection (STI) and considerations for their use of PrEP The risk of HIV among women after acquiring a sexually transmitted infection (STI) and considerations for their use of PrEP | The Ontario HIV Treatment Network The Ontario HIV Treatment Network The risk of HIV among women after acquiring a sexually transmitted infection (STI) and considerations for their use of PrEP The risk of HIV among women after acquiring a sexually (...) transmitted infection (STI) and considerations for their use of PrEP , , , , , , Questions What is the current evidence among women in high-income countries regarding HIV risk after acquiring a sexually transmitted infection (STI)? What does the evidence state regarding the use of pre-exposure prophylaxis (PrEP) to prevent HIV among women who have acquired an STI? Key take-home messages A recent study in the U.S. found that most women who were diagnosed with HIV did not have a reported STI in the past (1

2020 Ontario HIV Treatment Network

6. The risk factors for vitamin D deficiency in HIV positive patients: a meta-analysis

The risk factors for vitamin D deficiency in HIV positive patients: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2020 PROSPERO

7. The epidemiology of multi morbidities in HIV infected population in Sub-Sahara Africa: a systematic review and meta analysis

The epidemiology of multi morbidities in HIV infected population in Sub-Sahara Africa: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2020 PROSPERO

8. Trends in HIV testing and knowledge of HIV status among female sex workers in sub-Saharan Africa: a systematic review

Trends in HIV testing and knowledge of HIV status among female sex workers in sub-Saharan Africa: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2020 PROSPERO

9. Exploring the experiences of adherence to ART for young people with perinatally acquired HIV in low to middle-income countries through a materialism lens

Exploring the experiences of adherence to ART for young people with perinatally acquired HIV in low to middle-income countries through a materialism lens Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

10. Adolescent condom and contraceptive methods impact on HIV, STI and pregnancy: global systematic review of effectiveness and cost-benefit

Adolescent condom and contraceptive methods impact on HIV, STI and pregnancy: global systematic review of effectiveness and cost-benefit Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

11. Adherence to oral pre-exposure prophylaxis (PrEP) for HIV among young people: systematic review and meta-analysis

Adherence to oral pre-exposure prophylaxis (PrEP) for HIV among young people: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2020 PROSPERO

12. Do online support groups help individuals affected by HIV/AIDS? A systematic review of the quantitative and qualitative literature

Do online support groups help individuals affected by HIV/AIDS? A systematic review of the quantitative and qualitative literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2020 PROSPERO

13. Disability and HIV/AIDS: a systematic review

Disability and HIV/AIDS: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2020 PROSPERO

14. Summary of Cervical Cancer Screening Recommendations for Non-HIV Immunocompromised Women

Summary of Cervical Cancer Screening Recommendations for Non-HIV Immunocompromised Women (current immunosuppressants are listed in Table 2). Women with RA and IBD not on immunosuppressants and women with DM were considered at no increased risk compared with the general population. Screening recommendations based on these risks are summarizedinTable3. REFERENCES 1. GrulichAE,vanLeeuwenMT,FalsterMO,etal.Incidence ofcancersin peoplewithHIV/AIDScomparedwithimmunosuppressedtransplant recipients

2019 American Society for Clinical Pathology

15. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May (...) 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association , MD, MSc, FAHA, Chair , MD, Vice Chair , PhD , MD, MPH, FAHA , MD , MD, MSc , MD , MS , MD, FAHA , MD, MS Matthew J. Feinstein

2019 American Heart Association

16. HIV self-testing in high-income settings: Acceptability, potential benefits and harms, issues related to linkage to care, interventions to increase HIV self-testing

HIV self-testing in high-income settings: Acceptability, potential benefits and harms, issues related to linkage to care, interventions to increase HIV self-testing HIV self-testing in high-income settings: Acceptability, potential benefits and harms, issues related to linkage to care, interventions to increase HIV self-testing | The Ontario HIV Treatment Network The Ontario HIV Treatment Network HIV self-testing in high-income settings: Acceptability, potential benefits and harms, issues (...) related to linkage to care, interventions to increase HIV self-testing HIV self-testing in high-income settings: Acceptability, potential benefits and harms, issues related to linkage to care, interventions to increase HIV self-testing , , , , , Questions What is the current evidence in high-income settings on HIV self-testing related to acceptability, potential benefits and harms, issues related to the linkage to care after a positive test, and interventions to increase HIV self-testing? Key take

2019 Ontario HIV Treatment Network

17. Doravirine for the treatment of HIV-1 in adults

Doravirine for the treatment of HIV-1 in adults Clinical Commissioning Policy: Doravirine for the treatment of HIV-1 in adults NHS England Reference: 190137P Standard Operating Procedure: Clinical Commissioning Policy: Doravirine for the treatment of HIV-1 in adults First published: November 2019 Prepared by National Institute for Health and Care Excellence (NICE) Commissioning Support Programme Published by NHS England, in electronic format only. Contents Policy Statement 4 Equality Statement (...) 4 Plain Language Summary 5 1 Introduction 7 2 Definitions 9 3 Aims and Objectives 10 4 Epidemiology and Needs Assessment 10 5 Evidence Base 10 6 Criteria for Commissioning 18 7 Patient Pathway 19 8 Governance Arrangements 19 9 Mechanism for Funding 19 10 Audit Requirements 19 11 Documents which have informed this Policy 20 12 Date of Review 20 References 21 Policy Statement NHS England will commission doravirine for the treatment of HIV-1 in adults, in accordance with the criteria outlined

2019 NHS England

18. Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya Full Text available with Trip Pro

Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya Timely diagnosis of infant HIV infection is essential for antiretroviral therapy (ART) initiation. In a randomized controlled trial, we found the Texting Improves Testing (TextIT) intervention (a theory-based text messaging system) to be efficacious for improving infant HIV testing rates and maternal retention in prevention (...) of mother-to-child HIV transmission (PMTCT) programs. Using an implementation science approach, we aimed to evaluate real-world effectiveness of the intervention.In a pragmatic, cluster-randomized, stepped-wedge trial with 2 time periods of observation, we randomly allocated 10 clinics to begin implementing the intervention immediately and 10 clinics to begin implementing 6 months later. To approximate real-world conditions, inclusion criteria were broad. Women at clinics implementing the intervention

2019 EvidenceUpdates

19. Unmet needs of Indigenous peoples living with HIV

Unmet needs of Indigenous peoples living with HIV Unmet needs of Indigenous peoples living with HIV | The Ontario HIV Treatment Network The Ontario HIV Treatment Network Unmet needs of Indigenous peoples living with HIV Unmet needs of Indigenous peoples living with HIV , , , , , , , , , Questions What are the unmet needs of Indigenous peoples living with HIV? What interventions, strategies, and programs have been used to address these needs? Key take-home messages In 2016, First Nations, Métis (...) , and Inuit peoples accounted for 4.9% of the Canadian population but represented 11.3% of all new HIV infections (1). When considering Indigenous health, conventional approaches to HIV and other communicable diseases are insufficient (2). Considerable disconnect exists between the priorities of the HIV care cascade and the experiences of Indigenous peoples living with HIV (3). The lack of coordination between mainstream HIV biomedical approaches and Indigenous worldviews appears to contribute to poor

2019 Ontario HIV Treatment Network

20. Dolutegravir + rilpivirine (Juluca) dual therapy in HIV infection

Dolutegravir + rilpivirine (Juluca) dual therapy in HIV infection Prescrire IN ENGLISH - Spotlight ''Dolutegravir + rilpivirine (Juluca°) dual therapy in HIV infection'', 1 November 2019 {1} {1} {1} | | > > > Dolutegravir + rilpivirine (Juluca°) dual therapy in HIV infection Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Dolutegravir (...) + rilpivirine (Juluca°) dual therapy in HIV infection FEATURED REVIEW First-line therapy for patients with HIV infection is usually based on triple therapy. When sustained virological suppression has been achieved, treatment "simplification" can sometimes be considered. Is the two-drug regimen dolutegravir + rilpivirine (Juluca°) any better than other treatment options? Full review (3 pages) available for download by subscribers. Prescrire's rating NOTHING NEW In patients who have an undetectable viral load

2019 Prescrire